STEVEN MARX, MD
Osteopathic Medicine at 168 St, New York, NY
License number
New York 184140
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
2
630 WEST 168Th St, New York, NY 10032
1900 Hempstead Tpke SUITE 500, Hempstead, NY 11554
1900 Hempstead Tpke SUITE 500, Hempstead, NY 11554
Phone
(212) 305-4732
(212) 305-4825 (Fax)
(516) 542-1090
(516) 794-8165 (Fax)
(212) 305-4825 (Fax)
(516) 542-1090
(516) 794-8165 (Fax)
Personal information
See more information about STEVEN MARX at radaris.comName
Address
Phone
4 Walker Ave, Syosset, NY 11791
36 Andrea Ln, Thornwood, NY 10594
35 Juneau Blvd, Woodbury, NY 11797
667 Madison Ave FL 6, New York, NY 10065
11765 Broadway St, Alden, NY 14004
Organization information
See more information about STEVEN MARX at bizstanding.comSteven Marx MD
630 W 168 St, New York, NY 10032
Industry:
Cardiologist, Internist
Phone:
(212) 305-0271 (Phone)
Steven Owen Marx
Professional information
Use Of Rottlerin And Its Derivatives As Activators Of Bk Channel For Therapy Of Hypertension And Related Disorders
US Patent:
2009011, Apr 30, 2009
Filed:
Nov 18, 2005
Appl. No.:
11/792202
Inventors:
Steven O. Marx - New York NY, US
Sergey I. Zakharov - Fort Lee NJ, US
Sergey I. Zakharov - Fort Lee NJ, US
International Classification:
A61K 31/352, C07D 311/04
US Classification:
514456, 549405
Abstract:
The present invention provides compositions and methods for regulating the BK channel using rottlerin and derivatives thereof. In particular, the present invention provides pharmaceutical compositions for use in treating or preventing BK channel medicated disorders including hypertension and various hyperexcitability disorders. Also provided are compositions and methods for use in post-stroke neuroprotection and in treating or preventing erectile dysfunction. The present invention further provides kits for use in treating or preventing BK channel mediated disorders, comprising the compositions of the present invention.
Dr. Steven O Marx, New York NY - MD (Doctor of Medicine)
Specialties:
Cardiology, Clinical Cardiac Electrophysiology
Address:
Columbia University Medical Ctr
630 W 168Th St, New York 10032
(212) 305-4732 (Phone)
630 W 168Th St, New York 10032
(212) 305-4732 (Phone)
Certifications:
Cardiovascular Disease, 1995, Clinical Cardiac Electrophysiology, 1996, Internal Medicine, 2002
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Albany Medical College
Graduated: 1988
Strong Mem Hsp University Rochester
Vet Affairs Med Center
Albany Medical College
Graduated: 1988
Strong Mem Hsp University Rochester
Vet Affairs Med Center
Steven O Marx, New York NY
Specialties:
Cardiologist
Address:
630 W 168Th St, New York, NY 10032
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine), American Board of Internal Medicine Sub-certificate in Clinical Cardiac Electrophysiology (Internal Medicine)
Agent At Nationwide Bail
Position:
Agent at Nationwide Bail
Location:
Greater New York City Area
Industry:
Insurance
Work:
Nationwide Bail
-
Agent
Controlling Pathways That Regulate Muscle Contraction In The Heart
US Patent:
2003013, Jul 17, 2003
Filed:
Nov 5, 2002
Appl. No.:
10/288606
Inventors:
Andrew Marks - Larchmont NY, US
Steven Marx - New York NY, US
Steven Marx - New York NY, US
Assignee:
The Trustees of Columbia University - New York NY
International Classification:
A61K031/00, G01N033/53
US Classification:
435/007100, 514/001000
Abstract:
This invention provides methods of regulating contraction of a subject's heart and of treating heart failure and cardiac arrhythmia. This invention also provides methods of obtaining compounds that bind to, and activate or inhibit the activation of a type 2 ryanodine (RyR2) receptor, and methods for screening for compounds that alleviate heart disease.
Methods And Compositions For Treating Neointimal Hyperplasia
US Patent:
2009027, Nov 5, 2009
Filed:
Nov 25, 2008
Appl. No.:
12/323119
Inventors:
Andrew R. Marks - Larchmont NY, US
Steven O. Marx - New York NY, US
Steven O. Marx - New York NY, US
Assignee:
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK - New York NY
International Classification:
A61F 2/00, A61K 31/436
US Classification:
424423, 514291
Abstract:
The present invention relates to compositions containing an mTOR inhibitor, such as rapamycin or a rapamycin derivative, in combination with a PI3 kinase inhibitor and/or a leptin inhibitor, intraluminal devices configured to release such compositions, and methods for the treatment and/or prevention of intimal hyperplasia, vascular stenosis and/or restenosis comprising delivery of such compositions or intraluminal devices to subjects in need thereof. The compositions, intraluminal devices, and methods of the invention are particularly well-suited for the treatment or prevention of vascular stenosis and restenosis in obese and diabetic subjects.
P27 Prevents Cellular Migration
US Patent:
2003001, Jan 16, 2003
Filed:
Jun 14, 2002
Appl. No.:
10/172027
Inventors:
Andrew Marks - Larchmont NY, US
Steven Marx - New York NY, US
Steven Marx - New York NY, US
International Classification:
A61K031/00
US Classification:
514/001000
Abstract:
This invention provides methods of preventing cellular migration and of treating cardiovascular diseases and tumor metastasis by increasing the intracellular concentration of cyclin-dependent kinase inhibitor p27 or C3 exoenzyme or by decreasing the intracellular concentration of Rho-kinase, and methods of identifying chemical compounds for use in such treatments.
C3 Exoenzyme-Coated Stents And Uses Thereof For Treating And Preventing Restenosis
US Patent:
7662178, Feb 16, 2010
Filed:
Apr 29, 2008
Appl. No.:
12/150695
Inventors:
Steven O. Marx - New York NY, US
Andrew R. Marks - Larchmont NY, US
Andrew R. Marks - Larchmont NY, US
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61F 2/82, A61F 2/00
US Classification:
623 142, 623 143
Abstract:
This invention provides a stent for implantation in a blood vessel or other tissue, wherein the stent is coated with or contains C3 exoenzyme, a chimeric version thereof or an inhibitor of RhoA. This invention also provides a method for treating or inhibiting the onset of restenosis in a subject which comprises implanting one of the instant stents in the subject's blood vessel.
C3 Exoenzyme-Coated Stents And Uses Thereof For Treating And Preventing Restenosis
US Patent:
7364586, Apr 29, 2008
Filed:
Dec 20, 2002
Appl. No.:
10/326936
Inventors:
Steven O. Marx - New York NY, US
Andrew R. Marks - Larchmont NY, US
Andrew R. Marks - Larchmont NY, US
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61F 2/06, A61L 33/00
US Classification:
623 142, 623 148
Abstract:
This invention provides a stent for implantation in a blood vessel or other tissue, wherein the stent is coated with or contains C3 exoenzyme, a chimeric version thereof or an inhibitor of RhoA. This invention also provides a method for treating or inhibiting the onset of restenosis in a subject which comprises implanting one of the instant stents in the subject's blood vessel.
P27 Prevents Cellular Migration
US Patent:
2002009, Jul 25, 2002
Filed:
Jan 22, 2001
Appl. No.:
09/766944
Inventors:
Andrew Marks - Larchmont NY, US
Steven Marx - New York NY, US
Steven Marx - New York NY, US
International Classification:
A61K031/00, C12Q001/00, A61K031/4741
US Classification:
514/001000, 514/291000, 435/004000
Abstract:
This invention provides methods of preventing cellular migration and of treating cardiovascular diseases and tumor metastasis by increasing cyclin-dependent kinase inhibitor p27 activity, and methods of identifying chemical compounds for use in such treatments.